MARCY WORKMAN: Open Payments
NPI 1891751426 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,465 in 148 payments from 18 companies in 2025. Trend: 2023 $3,283 · 2024 $3,309 · 2025 $3,465
Food & beverage: $3,386Education: $79
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $664 |
| ABBVIE INC. | 30 | $563 |
| Regeneron Healthcare Solutions, Inc. | 13 | $447 |
| UCB, Inc. | 19 | $390 |
| Novartis Pharmaceuticals Corporation | 13 | $257 |
| LEO Pharma Inc. | 11 | $228 |
| Arcutis Biotherapeutics, Inc. | 9 | $221 |
| Amgen Inc. | 9 | $164 |
| GENZYME CORPORATION | 5 | $138 |
| E.R. Squibb & Sons, L.L.C. | 4 | $97 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Bimzelx, Zoryve, COSENTYX, Otezla, ADBRY.
Industry payments across KY — which companies pay providers there.
